(Q34301921)

1 August 2017

title

Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes (English)

1 reference

1 August 2017

0 references

0 references

Sunder Mudaliar

1

1 reference

1 August 2017

Debra A Armstrong

2

1 reference

1 August 2017

Annie A Mavian

3

1 reference

1 August 2017

Robin O'Connor-Semmes

4

1 reference

1 August 2017

Patricia K Mydlow

5

1 reference

1 August 2017

June Ye

6

1 reference

1 August 2017

Elizabeth K Hussey

7

1 reference

1 August 2017

Derek J Nunez

8

1 reference

1 August 2017

Robert R Henry

9

1 reference

1 August 2017

Robert L Dobbins

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

25 September 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

35

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

2198-2200

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

1 August 2017

copyright license

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Insulin-associated weight gain in diabetes--causes, effects and coping strategies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Molecular characteristics of Na(+)-coupled glucose transporters in adult and embryonic rat kidney

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476920

28 October 2018

Identifiers

DOI

10.2337/DC12-0508

1 reference

1 August 2017

1 reference

1 August 2017

1 reference